DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+34.45%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$3.43B
AUM Growth
+$3.43B
(+9%)
Cap. Flow
-$415M
Cap. Flow
% of AUM
-12.09%
Top 10 Holdings %
Top 10 Hldgs %
38.81%
Holding
112
New
25
Increased
11
Reduced
35
Closed
19
Top Buys
| 1 |
Hologic
HOLX
|
$78.1M |
| 2 |
Larimar Therapeutics
LRMR
|
$66.1M |
| 3 |
VIVO
Meridian Bioscience Inc
VIVO
|
$38.7M |
| 4 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$34.6M |
| 5 |
Generation Bio
GBIO
|
$24.9M |
Top Sells
| 1 |
AdaptHealth
AHCO
|
$255M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$219M |
| 3 |
Q32 Bio
QTTB
|
$62.7M |
| 4 |
IMMU
Immunomedics Inc
IMMU
|
$54.8M |
| 5 |
ABMD
Abiomed Inc
ABMD
|
$54.6M |
Sector Composition
| 1 | Healthcare | 65.56% |
| 2 | Financials | 0.55% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Viatris
VTRS
$12.3B
| $195M | 5.69% | 12,151,362 | – | – |
|
2
Schrodinger
SDGR
$1.44B
| $123M | 3.59% | 1,346,167 | – | – |
|
|
DFPHU
3
DELISTED
DFP Healthcare Acquisitions Corp. Unit
DFPHU
| $112M | 3.25% | 10,460,000 | – | – |
|
|
HZNP
4
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $108M | 3.16% | 1,951,211 -3,937,300 | -67% | -$219M |
|
|
IMMU
5
DELISTED
Immunomedics Inc
IMMU
| $90.8M | 2.64% | 2,561,000 -1,546,464 | -38% | -$54.8M |
|
6
Pacira BioSciences
PCRX
$1.2B
| $87.3M | 2.54% | 1,663,000 +35,479 | +2% | +$1.86M |
|
|
7
Hologic
HOLX
$14.9B
| $78.1M | 2.27% | +1,370,186 | New | +$78.1M |
|
|
MYOK
8
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $68M | 1.98% | 704,000 +357,591 | +103% | +$34.6M |
|
9
Mirum Pharmaceuticals
MIRM
$3.71B
| $67.1M | 1.95% | 3,448,912 | – | – |
|
|
10
Larimar Therapeutics
LRMR
$310M
| $66.1M | 1.93% | +5,144,539 | New | +$66.1M |
|
11
Revolution Medicines
RVMD
$7.1B
| $56.7M | 1.65% | 1,796,383 | – | – |
|
12
Centene
CNC
$14.3B
| $56.3M | 1.64% | 886,000 -381,206 | -30% | -$24.2M |
|
13
Rhythm Pharmaceuticals
RYTM
$6.85B
| $55.1M | 1.6% | 2,470,013 -561,552 | -19% | -$12.5M |
|
|
SWTX
14
DELISTED
SpringWorks Therapeutics
SWTX
| $51.8M | 1.51% | 1,234,262 +446,019 | +57% | +$18.7M |
|
|
AXNX
15
DELISTED
Axonics, Inc. Common Stock
AXNX
| $49.5M | 1.44% | 1,408,603 -385,991 | -22% | -$13.6M |
|
|
ORTX
16
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $43.6M | 1.27% | 7,259,988 -1,602,259 | -18% | -$9.61M |
|
17
McKesson
MCK
$85.4B
| $42.7M | 1.24% | 278,085 +102,648 | +59% | +$15.7M |
|
18
Vericel Corp
VCEL
$1.83B
| $42.3M | 1.23% | 3,057,161 -1,389,948 | -31% | -$19.2M |
|
19
Brookdale Senior Living
BKD
$1.83B
| $41M | 1.2% | 13,910,899 -4,491,456 | -24% | -$13.2M |
|
20
Alector
ALEC
$238M
| $41M | 1.19% | 1,676,997 -62,000 | -4% | -$1.52M |
|
|
RETA
21
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $40.8M | 1.19% | 261,765 +77,900 | +42% | +$12.2M |
|
|
XLRN
22
DELISTED
Acceleron Pharma Inc.
XLRN
| $40.2M | 1.17% | 421,619 +78,619 | +23% | +$7.49M |
|
|
VIVO
23
DELISTED
Meridian Bioscience Inc
VIVO
| $38.7M | 1.13% | +1,663,000 | New | +$38.7M |
|
|
XENT
24
DELISTED
Intersect ENT, Inc
XENT
| $34.9M | 1.02% | 2,576,879 -181,388 | -7% | -$2.46M |
|
25
Editas Medicine
EDIT
$231M
| $34.3M | 1% | 1,158,841 | – | – |
|